BUBOLight®, a New Phototherapy Device for the Treatment of the Newborn's Jaundice — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

BUBOLight®, a New Phototherapy Device for the Treatment of the Newborn's Jaundice — Stella

Recruiting

Back to Neonatal Jaundice trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Hop Jeanne de Flandre Chu Lille, Lille

Key details

Sponsor

University Hospital, Lille

Collaborators

Institut National de la Santé Et de la Recherche Médicale, France

Enrollment target

~15 participants

Started

October 2020

Primary completion

December 2026

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov